Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2002 2
2005 2
2006 3
2007 2
2008 3
2009 2
2010 3
2011 2
2013 4
2014 3
2015 2
2016 1
2017 5
2018 1
2019 4
2020 1
2021 6
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Bond MJG, Bolhuis K, Loosveld OJL, de Groot JWB, Droogendijk H, Helgason HH, Hendriks MP, Klaase JM, Kazemier G, Liem MSL, Rijken AM, Verhoef C, de Wilt JHW, de Jong KP, Gerhards MF, van Amerongen MJ, Engelbrecht MRW, van Lienden KP, Molenaar IQ, de Valk B, Haberkorn BCM, Kerver ED, Erdkamp F, van Alphen RJ, Mathijssen-van Stein D, Komurcu A, Lopez-Yurda M, Swijnenburg RJ, Punt CJA; Dutch Colorectal Cancer Study Group. Bond MJG, et al. Among authors: van amerongen mj. Lancet Oncol. 2023 Jul;24(7):757-771. doi: 10.1016/S1470-2045(23)00219-X. Epub 2023 Jun 14. Lancet Oncol. 2023. PMID: 37329889 Clinical Trial.
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
Bolhuis K, Bond MJG, Van Amerongen MJ, Komurcu A, Chapelle T, Dejong CHC, Engelbrecht MRW, Gerhards MF, Grünhagen DJ, van Gulik TM, Hermans JJ, De Jong KP, Kazemier G, Klaase JM, Kok NFM, Leclercq WKG, Liem MSL, van Lienden KP, Molenaar IQ, Neumann UP, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, May AM, Punt CJA, Swijnenburg RJ; Dutch Colorectal Cancer Group Liver Expert Panel. Bolhuis K, et al. Among authors: van amerongen mj. Eur J Cancer. 2023 Apr;183:49-59. doi: 10.1016/j.ejca.2023.01.013. Epub 2023 Jan 31. Eur J Cancer. 2023. PMID: 36801606 Free article. Clinical Trial.
Aneurysm diameter as a risk factor for pretreatment rebleeding: a meta-analysis.
Boogaarts HD, van Lieshout JH, van Amerongen MJ, de Vries J, Verbeek AL, Grotenhuis JA, Westert GP, Bartels RH. Boogaarts HD, et al. Among authors: van amerongen mj. J Neurosurg. 2015 Apr;122(4):921-8. doi: 10.3171/2014.12.JNS14931. Epub 2015 Feb 6. J Neurosurg. 2015. PMID: 25658785 Review.
Interobserver Variability in CT-based Morphologic Tumor Response Assessment of Colorectal Liver Metastases.
Wesdorp NJ, Kemna R, Bolhuis K, van Waesberghe JHTM, Nota IMGC, Struik F, Oulad Abdennabi I, Phoa SSKS, van Dieren S, van Amerongen MJ, Chapelle T, Dejong CHC, Engelbrecht MRW, Gerhards MF, Grünhagen D, van Gulik TM, Hermans JJ, de Jong KP, Klaase JM, Liem MSL, van Lienden KP, Molenaar IQ, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, Swijnenburg RJ, Punt CJA, Huiskens J, Stoker J, Kazemier G; Dutch Colorectal Liver Expert Panel. Wesdorp NJ, et al. Among authors: van amerongen mj. Radiol Imaging Cancer. 2022 May;4(3):e210105. doi: 10.1148/rycan.210105. Radiol Imaging Cancer. 2022. PMID: 35522139 Free PMC article. Clinical Trial.
E2F4 is required for cardiomyocyte proliferation.
van Amerongen MJ, Diehl F, Novoyatleva T, Patra C, Engel FB. van Amerongen MJ, et al. Cardiovasc Res. 2010 Apr 1;86(1):92-102. doi: 10.1093/cvr/cvp383. Epub 2009 Dec 2. Cardiovasc Res. 2010. PMID: 19955219
46 results